RNReza Nekouian

Reza Nekouian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Reza Nekouian has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Faranoush

    Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Dorsa Fallah Azad

    Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Fatemeh Khesali

    Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Negin Sadighnia

    Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Parisa Shams

    Cell and Developmental Biology Department, Faculty of sciences and advanced Technologies in biology, University of Science and Culture, ACECR, Tehran, Iran

    2 shared publications
  • Pooya Faranoush

    Pediatric Growth and Development Research Center, Institute of Endocrinology, Iran University of Medical Sciences, Tehran, Iran

    2 shared publications

Latest Publications

  • Open Access

    The impact of gut microbiota on leukemia and prospects for novel therapies

    by Saba Jalalifar, Bahar Bajelan, Reihane Mohammadi, Roya Ghafoury, Zahra Kalhori, Kamran Pooshang-Bagheri, Reza Nekouian, Mohammad Faranoush


  • Open Access

    Assessment of Expression LncRNA‐xloc‐000303, lncRNA‐LOC152578 and hsa‐miR‐29a in Patients Diagnosed With Colon Cancer in the Pre‐Treatment Stage

    by Elham Tahami, Abolfazl Akbari, Reza Nekouian

    Background: Employing a panel of biomarkers may enable the early diagnosis of colorectal cancer. Among these biomarkers, long non‐coding RNAs (LncRNAs) and microRNAs (miRNAs) are significant due to their crucial roles in biological and metabolic processes.Aims: Therefore, the objective of this research was to evaluate the diagnostic value of the biomarkers LncRNA‐xloc‐000303, lncRNA‐LOC152578, and miR‐29a in the pre‐treatment stage of colorectal cancer in Iranian patients.Materials and Methods: In this study, 30 tumor tissue samples and 30 adjacent healthy tissue samples were collected, and RNA was extracted using the Trizol kit. Subsequently, the relative expression of the candidate microRNA and LncRNAs was analyzed using real‐time PCR. The obtained gene expression data were then analyzed using REST software.Results: In this study, it was found that the expression of LncRNA‐xloc‐000303 in tumor tissues significantly increased compared to healthy tissue (p < 0.001). Additionally, the analysis revealed that the expression level of lncRNA‐LOC152578 showed an increase in tumor tissues compared to healthy tissues (p = 0.57), although these changes were not statistically significant. The results of the hsa‐miR‐29a expression analysis indicated a down regulation in tumor tissues compared to healthy tissues; however, this change was also not statistically significant (p = 0.34).Conclusion: The results indicated that the expression changes of LncRNA‐xloc‐000303 in cancer tissue were significant compared to adjacent healthy tissue, suggesting its potential use as a biomarker for diagnosing colorectal cancer. However, further studies are needed to evaluate the biomarker specificity of lncRNA‐LOC152578 and hsa‐miR‐29a. This study was conducted in an Iranian population and its results can be used in the future for personalized medicine in the prevention and treatment of colorectal cancer.

  • Open Access

    Insights into retinoblastoma pathogenesis: unraveling RB1, N-MYC and miRNA profiles

    by Mohammad Faranoush, Fatemeh Khesali, Pooya Faranoush, Mohammad Reza Foroughi-Gilvaee, Parisa Shams, Negin Sadighnia, Seyyed Amir Yasin Ahmadi, Dorsa Fallah Azad, Reza Nekouian

    Objective: Retinoblastoma is the most common paediatric intraocular malignancy, originating in neural retina germ cells. Early diagnosis is crucial for survival and eye preservation. This study analyses gene expression and specific microRNAs (miRNAs) in patients with retinoblastoma to enhance early diagnosis, prognosis and treatment strategies. Methods: This study examined gene and miRNA expression in 18 patients with retinoblastoma and 10 healthy individuals. Peripheral blood samples were collected from all participants, and patient demographics were recorded. The analysis was performed using real-time PCR targeting the RB1 and N-MYC genes, along with the miRNAs miR-125-5p, miR-221-3p and miR-519-3p. Results: The patient group consisted of 18 participants (9 males, 9 females), aged between 2 and 6 years (mean±SD: 4.8±1.33 years), with a mean diagnosis age of 3.01±1.37 years. All participants were followed for 3 years, with no fatalities. The control group comprised 10 participants (4 males, 6 females), aged 2–8 years (mean±SD: 5.01±1.77 years). 11 patients underwent enucleation due to tumour progression: 3 right eyes and 8 left eyes. Gene expression analysis showed significant downregulation of miR-125-5p, miR-519-3p and NMYC in the retinoblastoma group. RB1 downregulation and miR-221-3p upregulation were noted in most patients, but without significant associations. Conclusion: miRNAs, along with RB1 and N-MYC genes, may serve as predictive and prognostic biomarkers in retinoblastoma. While previous studies have highlighted the impact of certain miRNAs on survival and clinical outcomes, our study is limited by a small sample size and lack of strong statistical correlations. Large-scale studies are needed to validate these preliminary findings and clarify their clinical significance. Understanding the role of miRNAs in cancer biology could improve retinoblastoma mechanism insights and patient care.

  • Open Access

    ATP‐Binding Cassette Transporter Genes and microRNAs in Pediatric B‐Cell ALL: Expression Insights

    by Reza Nekouian, Pooya Faranoush, Fatemeh Khesali, Parisa Shams, Mohammad Reza Foroughi‐Gilvaee, Negin Sadighnia, Dorsa Fallah Azad, MohammadAli Ehsani, Mohammad Faranoush

    Background: Acute lymphocytic leukemia (ALL), characterized by uncontrolled growth of abnormal lymphocytes, predominantly affects children. Genetic analysis focusing on genes and microRNAs reveals important information about the biology of ALL, enabling accurate diagnosis and treatment. This study examines gene and microRNA expression in B cell ALL to improve early diagnosis and personalized treatment.Methods: Bone marrow samples were collected from patients both before and after the induction phase of chemotherapy. Comprehensive diagnostic techniques including flow cytometry, molecular assays, real‐time PCR for common translocations, karyotyping, and complete blood count (CBC) analysis were employed. These methods were utilized to determine the type and risk assessment of ALL, identify specific gene and microRNA expressions, and measure blood cell counts.Results: The study comprised 12 patients, all under the age of 18. Post‐treatment RT‐PCR analysis revealed significant reductions in the expression of the ABCB1 gene, miR‐129‐5p, and miR‐9‐5p following the induction phase of chemotherapy. Karyotype analysis indicated that two patients were hypodiploid; unfortunately, both of these patients did not survive.Conclusion: MicroRNAs and ABC genes serve as predictive and prognostic biomarkers in Acute Lymphoblastic Leukemia (ALL) and should be carefully reconsidered. It is more accurate to state that while microRNAs and ABC genes may potentially influence treatment response in ALL, further research is crucial to fully understand their roles in determining treatment outcomes.


  • Investigation of Some Selected micro RNAs Association with Aggressiveness of Tumor Pathology in Cases of Papillary Thyroid Carcinoma

    by Sara Nazari, Ahmad Majd, Iraj Heydari, Mohammad Reza Mohajeri Tehrani, Reza Nekouian

    Background & Aims: Papillary thyroid carcinoma (PTC) is the most prevalent thyroid gland tumor arising from thyroid follicular cells. MicroRNAs (miRs) are endogenous single‑stranded non‑coding RNAs attaching to the different sites of the target mRNAs, leading to regulation of gene expression. Hence, miRs play a role in biological functions. Diagnostic role ...

  • Open Access

    Impact of Smoking on MicroRNAs in Atherosclerotic Coronary Artery Disease

    by Shokoufeh Hajsadeghi, Aida Iranpour, Shayan Mirshafiee, Reza Nekouian, Maryam Mollababaei, Hamed Motevalli, Seyyed Amir Yasin Ahmadi, Mohammad Sedigh Dakkali

    Introduction: Given the importance of coronary artery disease and the range of cardiovascular disease phenotypes in smokers, as well as the potential genetic and epigenetic factors, we were motivated to explore the impact of smoking on some selected microRNAs associated with atherosclerosis. Methods: A total of 60 individuals were selected in four groups including non-smoker without atherosclerosis (S-A-), non-smokers with atherosclerosis (S-A+), smokers without atherosclerosis (S+A-) and smokers with atherosclerosis (S+A+). Micro-RNA expression was investigated using real-time PCR. General linear model was used to calculate fold change (FC) considering S-A- as the reference group. Results: For mir-34a, down-regulation was observed in S+A- (FC =0.13, P =0.007) and S+A+ (FC =0.23, P =0.036) groups. For mir-126-3p, down-regulation was observed in S-A+ group (FC =0.05, P =0.024). For mir-199, up-regulation was observed for S+A- group (FC =9.38, P =0.007). The only significant interaction between pack-years of smoking and number of atherosclerotic vessels was for mir-199 which was in favor of down-regulation (P =0.006), while the main effects were in favor of up-regulation (P Conclusion: Mir-34a expression may be affected by smoking, whereas mir-126-3p expression may be affected by atherosclerosis. The significant down-regulation of mir-199 for the interaction of smoking dose and severity of atherosclerosis was a notable finding showing the harmful consequence of this interaction. Further studies are needed for this micro-RNA.

  • Open Access

    Role of curcumin on miR-26a and its effect on DNMT1, DNMT3b, and MEG3 expression in A549 lung cancer cell

    by Zahra Mahmoudi, Mojtaba Jahani, Reza Nekouian

    Context: Most of the patients diagnosed with non-small cell lung cancer (NSCLC) are in their advanced stages and as a result might not be cured in spite of the advances in aimed therapy. In the recent years, the role of noncoding RNAs (ncRNAs) has been expanded to cancer as potential targets for RNA-based epigenetic therapies. Curcumin, as an active ingredient, is associated with epigenetic alterations, and it might modulate the expression of tumor suppressor and oncogenic microRNAs. Materials and Methods: In this study, we investigated the RNA-based epigenetic effects of curcumin on NSCLC, and the effect of curcumin on A549 cell viability was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The expression of miR-26a, MEG3, DNA methyltransferase 1 (DNMT1), and DNMT3 beta (DNMT3b) was assessed by quantitative polymerase chain reaction. Statistical Analysis Used: Data analysis was done using Prism®6 software (GraphPad Software, Inc., La Jolla, CA, USA), and statistical analysis was performed using t-test between control and vitality samples. Results: The results showed a significant increase (P < 0.05) of miR-26a expression which in turn was associated with a significant decrease (P < 0.05) in expression of DNMTs and subsequently a significant increase in MEG3 expression (P < 0.05) in A549 cell line after adding curcumin in the media. Conclusion: Considering all the data together, we could speculate the role of curcumin in ceasing the progression of cancer in its early stages and might be considered a potential drug for the treatment of NSCLC-derived lung cancer by establishing a meaningful relationship between epigenetic mechanisms and ncRNAs.


  • Nanocomposite scaffold seeded with mesenchymal stem cells for bone repair

    by Maryam Farshadi, Behrooz Johari, Elham Erfani Ezadyar, Mazaher Gholipourmalekabadi, Mahmoud Azami, Hamid Madanchi, Seyed Mohammad Amin Haramshahi, Abazar Yari, Ayoob Karimizade, Reza Nekouian, et al.

    Mechanical property of bone tissue scaffolds is one of the most important aspects in bone tissue engineering that has remained problematic. In our previous study, we fabricated a 3D scaffold from nano‐hydroxyapatite/gelatin (nHA/Gel) and investigated its efficiency in promoting bone regeneration both in vitro and in vivo. In the present study, the effect of adding silicon carbide (SiC) on mechanical and biological behaviors of the nHA/Gel/SiC and bone regeneration in vivo were determined. nHA and SiC were synthesized and characterized by XRD pattern and TEM image. Layer solvent casting, freeze‐drying, and lamination techniques were applied to prepare these scaffolds. Then, biocompatibility and cell adhesion behavior of synthesized nHA/Gel/SiC scaffolds were investigated. For in vivo studies, rats were categorized into three groups: blank defect, blank scaffold, and rat bone marrow mesenchymal stem cells (rBM‐MSCs)/scaffold. After 1, 4, and 12 weeks post‐injury, rats were sacrificed and the calvaria were harvested. Sections of 5µm thickness were prepared and stained with Hematoxylin‐eosin, Masson's Trichrome, and Immunohistochemistry. Our results showed that SiC effectively increased the mechanical properties of the nHA/Gel/SiC scaffold. No significant differences were observed in biocompatibility, cell adhesion, and cytotoxicity of the nHA/Gel/SiC in comparison to the nHA/Gel nano‐composite. Based on the histological and immunohistochemical studies, both osteogenesis and collagenization were significantly higher in the rBM‐MSCs/scaffold group, quantitatively and qualitatively. The present study strongly suggests potential of SiC as an alternative strategy to improve mechanical and biological properties of bone tissue engineering scaffolds, and shows that pre‐seeded nHA/Gel/SiC scaffold with rBM‐MSCs improve osteogenesis in the engineered bone implant.